Welcome to our dedicated page for Encompass Health news (Ticker: EHC), a resource for investors and traders seeking the latest updates and insights on Encompass Health stock.
Encompass Health Corp (EHC) operates one of the nation's largest networks of inpatient rehabilitation hospitals, offering post-acute care through advanced therapies and home health services. This page aggregates official press releases and verified news about the company's financial performance, operational developments, and healthcare innovations.
Investors and stakeholders will find timely updates on earnings reports, strategic partnerships, and regulatory compliance matters. Content spans facility expansions, technology implementations like DesignManufactureConstruct™, and service enhancements across rehabilitation and hospice care.
All materials are curated to provide a comprehensive view of EHC's market position without speculative commentary. Bookmark this page for direct access to primary sources about the company's progress in delivering coordinated, patient-centered care nationwide.
Encompass Health (NYSE: EHC) has promoted Patrick Tuer to the newly created position of Chief Operating Officer (COO), effective immediately. Tuer, previously serving as group president overseeing 69 hospitals across three geographic regions, will now manage hospital operations across the entire organization, reporting to CEO Mark Tarr.
The promotion comes amid significant growth through the company's accelerated de novo program and capacity additions to existing hospitals. Since joining in 2018, Tuer has held various leadership roles including regional president and regional vice president, demonstrating success in driving volume growth, operational improvements, and enhanced patient outcomes.
The appointment aligns with Encompass Health's strategy of expanding access to rehabilitative care while improving performance across their operations. The company reports having a robust development pipeline with expectations for continued growth.
Encompass Health (NYSE: EHC) reported strong Q1 2025 financial results with significant growth across key metrics. Net operating revenue increased 10.6% to $1,455.4 million, driven by a 6.3% growth in total discharges and a 3.9% increase in net patient revenue per discharge.
The company's performance showed notable improvements with income from continuing operations per diluted share rising 33.3% to $1.48, while adjusted earnings per share grew 22.3% to $1.37. Cash flows from operating activities increased 20.9% to $288.6 million, and Adjusted EBITDA rose 14.9% to $313.6 million.
During Q1, EHC expanded its capacity by opening a new 40-bed hospital and adding 25 beds to existing facilities. Based on strong performance, the company increased its full-year 2025 guidance, projecting net operating revenue of $5,850-$5,925 million and adjusted earnings per share of $4.85-$5.10.
Encompass Health (NYSE: EHC) has announced plans to construct a new 50-bed inpatient rehabilitation hospital in St. George, Utah. The freestanding facility, set to open in 2027, will be the company's second location in Utah.
The hospital will provide specialized care for patients recovering from various conditions including strokes, neurological disorders, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions. The facility will feature private patient rooms, advanced rehabilitation technologies, an activities of daily living suite, in-house dialysis suite, pharmacy, and therapy courtyard.
The new facility will offer 24-hour nursing care along with physical, occupational, and speech therapies, delivered by specialized healthcare professionals to help restore patients' functional ability and quality of life.
Encompass Health (NYSE: EHC) has announced its annual stockholder meeting will be held virtually on Thursday, May 1, 2025 at 11:00 a.m. CDT.
Stockholders of record as of March 7, 2025 can participate in the meeting through virtualshareholdermeeting.com/EHC2025. To join or vote, stockholders must use their 16-digit control number found on their Notice of Internet Availability of Proxy Materials or proxy card.
The virtual meeting platform will be accessible 15 minutes before the start time, and an archived recording will be available for replay after the event.
Encompass Health (NYSE: EHC) has announced a change in the timing of its 2025 first quarter earnings conference call, which will now take place at 9 a.m. ET on Friday, April 25, 2025, instead of the previously scheduled 10 a.m. ET time slot.
The company will release its Q1 2025 financial results, covering the period ended March 31, 2025, after market close on Thursday, April 24, 2025. Investors can join the conference call by dialing 800-245-3047 (US) or 203-518-9765 (International) with the conference ID EHCQ125. A live webcast and replay will be available on the company's investor website.
Encompass Health (NYSE: EHC) has scheduled its first quarter 2025 earnings release and conference call. The company will announce its Q1 2025 financial results, covering the period ended March 31, 2025, after market close on Thursday, April 24, 2025.
The investor conference call is scheduled for Friday, April 25, 2025, at 10 a.m. ET. Investors can join via phone by dialing 800-245-3047 (US) or 203-518-9765 (International) using conference ID EHCQ125. A live webcast and replay will be available on the company's investor website.
Encompass Health (EHC) and Piedmont have announced the opening of the Rehabilitation Hospital of Athens in Georgia, a 40-bed inpatient facility located at 1083 Parkway Blvd. This joint venture represents EHC's 167th rehabilitation hospital nationwide and 8th location in Georgia.
The facility offers specialized care for patients recovering from strokes, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions. Patients receive minimum three hours of intensive therapy five days weekly, frequent physician visits, and 24-hour nursing care.
The hospital features private patient rooms, advanced rehabilitation technologies, an activities suite, in-house dialysis suite, therapy courtyard, dining room, pharmacy, and dayroom areas. This marks the seventh operational joint venture between Encompass Health and Piedmont, with plans announced for an additional facility in Loganville, Georgia.
Encompass Health (NYSE: EHC) has announced its participation in the upcoming Barclays Global Healthcare Conference, scheduled for March 11-13, 2025. The company's presentation will feature President and CEO Mark Tarr alongside Executive VP and CFO Doug Coltharp.
The presentation is set for Tuesday, March 11, 2025, from 8:30 to 8:55 AM ET. Investors and interested parties can access the live webcast through the company's investor relations website at http://investor.encompasshealth.com.
Encompass Health (NYSE: EHC) has announced a quarterly cash dividend declaration by its board of directors. Shareholders will receive $0.17 per share as a cash dividend. The dividend will be paid on April 15, 2025, to stockholders who are registered as holders of record on April 1, 2025.
Encompass Health (NYSE: EHC) reported strong Q4 2024 results with significant growth across key metrics. Net operating revenue increased 12.7% to $1,405.0 million, driven by a 7.8% growth in discharges and 4.2% increase in net patient revenue per discharge. Same-store discharge growth was 5.8%.
The company's income from continuing operations per diluted share rose 25.5% to $1.18, while adjusted earnings per share increased 23.2% to $1.17. Cash flows from operating activities grew 38.7% to $278.8 million, and adjusted EBITDA improved 13.6% to $289.6 million.
For 2025, EHC provided guidance projecting net operating revenue between $5,800 to $5,900 million, adjusted EBITDA of $1,160 to $1,200 million, and adjusted earnings per share from continuing operations of $4.67 to $4.96.
